ICD-9-CM Diagnosis Code 052.9 : Varicella without mention of complication. ICD-9-CM 052.9 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 052.9 should only be used for claims with a date of service on or before September 30, 2015.
What ICD-10 covers varicella titer?
B01. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM B01. 9 became effective on October 1, 2021.
What is the ICD 10 code for varicella?
ICD-10 code B01 for Varicella [chickenpox] is a medical classification as listed by WHO under the range - Certain infectious and parasitic diseases .
What is the code for chickenpox?
B01: Varicella [chickenpox]
Is there a chickenpox vaccine?
There are 2 vaccines that protect against chickenpox: The chickenpox vaccine protects children and adults from chickenpox. The MMRV vaccine protects children from measles, mumps, rubella, and chickenpox.
Which patient should not receive the varicella vaccine?
Contraindications for Varicella Vaccination. People with contraindications for varicella vaccine should not receive varicella vaccine, including anyone who: has a history of anaphylactic/anaphylactoid reaction to gelatin, neomycin, or any other component of the vaccine.
When do you get chicken pox vaccine?
CDC recommends two doses of chickenpox vaccine for children, adolescents, and adults. Children should receive two doses of the vaccine—the first dose at 12 through 15 months old and a second dose at 4 through 6 years old.
How many doses of varicella vaccine are needed for adults?
Varicella vaccination All adults without evidence of immunity to varicella (as defined below) should receive 2 doses of single-antigen varicella vaccine or a second dose if they have received only 1 dose.
Indications and Usage For Varivax
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Varivax Description
Varivax - Clinical Pharmacology
- Mechanism of Action
Varivax induces both cell-mediated and humoral immune responses to varicella-zoster virus. The relative contributions of humoral immunity and cell-mediated immunity to protection from varicella are unknown. - Pharmacodynamics
Transmission In the placebo-controlled efficacy trial, transmission of vaccine virus was assessed in household settings (during the 8-week postvaccination period) in 416 susceptible placebo recipients who were household contacts of 445 vaccine recipients. Of the 416 placebo recipients, three developed varicella and seroconverted, n…
See more on drugs.com
Clinical Studies